Patents by Inventor Joseph Belanoff

Joseph Belanoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating psychosis associated with interferson-alpha therapy
    Publication number: 20060063748
    Abstract: The present invention relates to the treatment of psychosis associated with interferon-therapy. The present invention further relates to kits for the treatment of Hepatitis C in a patient.
    Type: Application
    Filed: July 2, 2003
    Publication date: March 23, 2006
    Applicant: Corcept Therapeutics, Inc.
    Inventor: Joseph Belanoff
  • Methods for treating migraine
    Publication number: 20060052354
    Abstract: This invention relates to the discovery that agents capable of inhibiting the biological action of the glucocorticoid receptor can be used in methods for treating migraine in a subject.
    Type: Application
    Filed: November 5, 2003
    Publication date: March 9, 2006
    Applicant: Corcept Therapeutics, Inc.
    Inventor: Joseph Belanoff
  • Glucocorticoid blocking agents for increasing blood-brain barrier permeability stan-261con
    Publication number: 20050124533
    Abstract: Glucocorticoid blockers, including glucocorticoid receptor antagonists, are effective to prevent glucocorticoid-induced decrease in permeability of the blood-brain barrier and to increase the permeability of the blood-brain barrier. Administration of glucocorticoid blockers, including glucocorticoid receptor antagonists, concomitant with administration of drugs for treating diseases of the central nervous system increases delivery of such drugs into the central nervous system.
    Type: Application
    Filed: September 24, 2004
    Publication date: June 9, 2005
    Inventors: Alan Schatzberg, Steven Lindley, Joseph Belanoff
  • Antiglucocorticoids for the treatment of catatonia
    Publication number: 20050080066
    Abstract: The invention provides a method of ameliorating the symptoms of catatonia in a patient who is in need of treatment for catatonia. The method comprises administration of a therapeutically effective amount of a glucocorticoid receptor antagonist to the patient.
    Type: Application
    Filed: July 20, 2004
    Publication date: April 14, 2005
    Applicant: Corcept Therapeutics, Inc.
    Inventor: Joseph Belanoff
  • Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
    Publication number: 20050080061
    Abstract: This invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for preventing neurological damage associated with glucocorticoid therapy in ventilator-dependent low birth weight preterm infants. Mifepristone, a potent glucocorticoid receptor antagonist, can be used in these methods.
    Type: Application
    Filed: July 20, 2004
    Publication date: April 14, 2005
    Applicant: Corcept Therapeutics, Inc.
    Inventor: Joseph Belanoff